DarioHealth Corp (NAS:DRIO)
$ 0.92 -0.0502 (-5.17%) Market Cap: 28.82 Mil Enterprise Value: 36.51 Mil PE Ratio: 0 PB Ratio: 0.41 GF Score: 62/100

Q2 2019 DarioHealth Corp Earnings Call Transcript

Aug 13, 2019 / 01:00PM GMT
Release Date Price: $8.4 (-25.66%)
Operator

Good day, ladies and gentlemen, and welcome to DarioHealth Second Quarter 2019 Earnings Call.

Hosting the call today are Erez Raphael, Chief Executive Officer; Olivier Jarry, President and Chief Commercial Officer; and Zvi Ben-David, Chief Financial Officer.

Before I turn the call over to management, I'd like to remind everyone that during the course of this call, management will make express and imply forward-looking statements within the Private Securities Litigation Reform Act of 1995 and other U.S. federal securities laws. DarioHealth does not assume any obligation to update that information.

Actual events or results may differ materially from those projected as a result of changing market trends, reduced demand and the competitive nature of DarioHealth's industry. Such forward-looking statements and their implications involve known and unknown risks, uncertainties and other factors that may cause actual results or performance to differ materially from those projected. The forward-looking statements discussed on this call are subject to other risks and uncertainties,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot